Hims lawsuit is Novo's first US patent case over Wegovy compounding Novo previously sued small compounders for false advertising, trademark issues Patent lawsuits are more complex but could lead to ...
Novo Nordisk, a Danish pharmaceutical company, manufactures the weight loss and diabetes medications Ozempic and Wegovy. The company is seeking damages and the banning of the copycat medication, ...
Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Ed Silverman, a senior ...
LONDON, Feb 5 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab CEO Mike Doustdar was in a meeting with investors on Thursday discussing the company's tough recent outlook when one interrupted him ...
Novo Nordisk accuses Hims & Hers of ‘illegal mass compounding’ over a cheaper version of Wegovy pill
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...
Novo Nordisk’s U.S.-traded shares slid 15% Tuesday after the drugmaker unexpectedly warned that its 2026 sales would decline more sharply than expected, as pricing pressure weighs on U.S. sales of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results